Literature DB >> 8690508

Overexpression of bax sensitizes human breast cancer MCF-7 cells to radiation-induced apoptosis.

C Sakakura1, E A Sweeney, T Shirahama, Y Igarashi, S Hakomori, H Nakatani, H Tsujimoto, T Imanishi, M Ohgaki, T Ohyama, J Yamazaki, A Hagiwara, T Yamaguchi, K Sawai, T Takahashi.   

Abstract

Resistance to apoptosis plays an important role in tumors that are refractory to chemotherapy and ionizing radiation (IR). bax, which forms a heterodimer with bcl-2 and accelerates apoptosis, is not, or only weakly, expressed in most human breast cancer cells, and weak bax expression is considered to be related to the resistance of breast cancer cells to apoptosis. bax expression vector was introduced to human breast cancer MCF-7 cells, which exhibit weak expression of bax, to demonstrate its role of modulating radiation-induced apoptosis. bax overexpression in MCF-7 cells by stable transfection does not affect viability by itself, but each stable transfectant was more sensitive to IR than the parental MCF-7 cells. The degree of enhancement in radiosensitivity was dependent on the expression level of bax. IR upregulated p53 and p21WAF1 about 5- to 10-fold and downregulated bcl-2 and bcl-XL by 80-90% at 6 hr in both parent and bax stably transfected MCF-7 cells to the same degree. FACS analysis and DNA electrophoresis revealed that this sensitization was due to apoptosis. We suggest that exogenous bax expression might be one of the factors determining cellular radiosensitivity in MCF-7 breast cancer cells and may have therapeutic applications for enhancing radiation sensitivity in breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8690508     DOI: 10.1002/(SICI)1097-0215(19960703)67:1<101::AID-IJC17>3.0.CO;2-H

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  24 in total

Review 1.  Gene therapy in lung cancer.

Authors:  S G Swisher; J A Roth
Journal:  Curr Oncol Rep       Date:  2000-01       Impact factor: 5.075

2.  Driving p53 response to Bax activation greatly enhances sensitivity to taxol by inducing massive apoptosis.

Authors:  P De Feudis; S Vignati; C Rossi; T Mincioni; R Giavazzi; M D'Incalci; M Broggini
Journal:  Neoplasia       Date:  2000 May-Jun       Impact factor: 5.715

Review 3.  Gene therapy for carcinoma of the breast.

Authors:  M A Stoff-Khalili; P Dall; D T Curiel
Journal:  Cancer Gene Ther       Date:  2006-01-06       Impact factor: 5.987

4.  The potential role of BAX and BCL-2 expression in diffuse alveolar damage.

Authors:  D Guinee; E Brambilla; M Fleming; T Hayashi; M Rahn; M Koss; V Ferrans; W Travis
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

5.  BCL-2 family protein expression in initial and recurrent glioblastomas: modulation by radiochemotherapy.

Authors:  H Strik; M Deininger; J Streffer; E Grote; J Wickboldt; J Dichgans; M Weller; R Meyermann
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-12       Impact factor: 10.154

6.  BCL-2 family proteins modulate radiosensitivity in human malignant glioma cells.

Authors:  Johannes R Streffer; Andreas Rimner; Johannes Rieger; Ulrike Naumann; Hans-Peter Rodemann; Michael Weller
Journal:  J Neurooncol       Date:  2002-01       Impact factor: 4.130

7.  Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression.

Authors:  Geza Acs; Paul J Zhang; Cindy M McGrath; Peter Acs; John McBroom; Ahmed Mohyeldin; Suzhen Liu; Huasheng Lu; Ajay Verma
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

8.  Molecular therapy for peritoneal dissemination of xenotransplanted human MKN-45 gastric cancer cells with adenovirus mediated Bax gene transfer.

Authors:  Y Tsunemitsu; S Kagawa; N Tokunaga; S Otani; T Umeoka; J A Roth; B Fang; N Tanaka; T Fujiwara
Journal:  Gut       Date:  2004-04       Impact factor: 23.059

Review 9.  Modulating the Radiation Response for Improved Outcomes in Breast Cancer.

Authors:  Andrea M Pesch; Lori J Pierce; Corey W Speers
Journal:  JCO Precis Oncol       Date:  2021-01-25

10.  Radish (Raphanus sativus L. leaf) ethanol extract inhibits protein and mRNA expression of ErbB(2) and ErbB(3) in MDA-MB-231 human breast cancer cells.

Authors:  Woo Kyoung Kim; Ji Hae Kim; Da Hee Jeong; Young Hee Chun; Sun Hee Kim; Kang Jin Cho; Moon-Jeong Chang
Journal:  Nutr Res Pract       Date:  2011-08-31       Impact factor: 1.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.